Biomea Fusion To Report Results From Phase I GLP-131 Clinical Study Evaluating BMF-650, Investigational Next-Gen Oral Small-Molecule GLP-1 Receptor Agonist, On October 13

Benzinga

2026.10.12 20:32 (GMT+0)

Открыть на Benzinga